# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marie Curie (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET013-SYN
- Date: 2026-05-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Adaeze Nwosu, MD
- Calendar frame: modern shifted

## What we are working on

- Exhausted and short of breath for two months, with bruises she cannot explain **S**
- Wonders whether her years of radiation work caused this, and wants her laboratory staff protected **S**
- Blurred, glary vision in the right eye is slowing her reading **S**

## Your goals

- Hematology evaluation with bone marrow biopsy within one week of the pancytopenia result. Target: 2026-05-18. Recorded outcome: Seen and biopsied seven days after the first visit. **S**
- No serious infection or bleeding during the first months of treatment. Target: 2026-06-29. Recorded outcome: No infection or bleeding through the sixth week of therapy. **S**
- Early rise in neutrophil and platelet counts by the six-week visit. Target: 2026-06-29. Recorded outcome: Neutrophils rose from 0.4 to 0.8 and platelets from 18 to 34 thousand per microliter; formal response is judged at three to six months. **S**
- Read standard print comfortably with the right eye after capsulotomy. Target: 2026-06-29. Recorded outcome: Reading without glare one week after laser capsulotomy. **S**

## What we agreed to do

- Urgent hematology referral for pancytopenia with a low reticulocyte count, for bone marrow aspirate and biopsy, cytogenetics, and PNH testing. Guideline: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024) **S**
- Initial anemia workup in primary care: CBC with differential and reticulocyte count, blood film, vitamin B12, folate, ferritin, LDH, bilirubin, and kidney function. Guideline: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024); CMID: Clinical Monitoring Intelligence Database, anemia and cataract monographs (2026) **S**
- Supportive care: irradiated, leukocyte-depleted red cells for symptomatic anemia; platelet thresholds set by hematology; same-day assessment for a temperature of 38 °C or higher; avoid aspirin and NSAIDs. Guideline: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024) **S**
- Record cumulative occupational radiation exposure, stop further exposure while counts recover, and review shielding and dosimetry for laboratory staff with occupational health. Guideline: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024) **S**
- First-line immunosuppressive therapy given by hematology: horse antithymocyte globulin with cyclosporine and eltrombopag, plus acyclovir prophylaxis; inactivated vaccines only. Guideline: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024) **S**
- Monitor CBC weekly during the first months of treatment, with kidney function, potassium, and ALT every two weeks on cyclosporine and eltrombopag. Guideline: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024); CMID: Clinical Monitoring Intelligence Database, anemia and cataract monographs (2026) **S**
- Comprehensive dilated eye examination with best-corrected acuity, intraocular pressure, slit-lamp examination, and a functional vision assessment; YAG laser capsulotomy when capsule opacification limits daily tasks; eye examinations every one to two years afterward. Guideline: Cataract in the Adult Eye Preferred Practice Pattern (2021); CMID: Clinical Monitoring Intelligence Database, anemia and cataract monographs (2026) **S**

## Follow-up

- 2026-05-11: Primary care visit for two months of fatigue, breathlessness on stairs, easy bruising, and a recent fever **S**
- 2026-05-18: Hematology consultation with bone marrow aspirate and biopsy for pancytopenia **S**
- 2026-06-08: Primary care follow-up three weeks after starting immunosuppressive therapy, with a cataract and eye review **S**
- 2026-06-29: Primary care follow-up six weeks into immunosuppressive therapy, after laser capsulotomy of the right eye **S**

This teaching document does not replace care from a qualified clinician.
